An Early Phase 1 interventional study of Apsara Thermal Wand System in Tightening of Skin Laxity, sponsored by Apsara Medical Corporation. Completed at 1 site in United States. Open to participants aged 40 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2009-08-28.
Sponsored by Apsara Medical Corporation · Early Phase 1, Interventional, and Treatment
The purpose of this feasibility study is to gain an initial assessment of the acute safety and performance of the Apsara Thermal Wand System in human facial tissue.
147 studies on the registry are indexed under Cutis Laxa; 35 are open to participants now.
This study's enrollment of 4 is below the median of 30 across 129 interventional studies indexed under Cutis Laxa.
Browse Cutis Laxa studies →This is the only study on the registry with Apsara Medical Corporation as lead sponsor.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Device: Apsara Thermal Wand System
Single radiofrequency cycle to dermal tissue
Serious Adverse Events
Number of Serious Adverse Events
Time frame: Immediate
| Milestone | A--Thermal Wand Application |
|---|---|
| Started | 4 |
| Completed | 4 |
| Not completed | 0 |
Number of Serious Adverse Events
| Number of Serious Adverse Events | A--Thermal Wand Application |
|---|---|
| Serious Adverse Events | 0 |
| Age, Categorical(Participants) | A--Thermal Wand Application |
|---|---|
| <=18 years | 0 |
| Between 18 and 65 years | 3 |
| >=65 years | 1 |
| Age Continuous(years) | A--Thermal Wand Application |
|---|---|
| Mean | 61.7 ± 3.6 |
| Sex: Female, Male(Participants) | A--Thermal Wand Application |
|---|---|
| Female | 4 |
| Male | 0 |
| Region of Enrollment(participants) | A--Thermal Wand Application |
|---|---|
| United States | 4 |
This study is completed, as verified in Jul 2009. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.